In addition, we found that RAI2 inhibits the stem cell-like properties of CRC cells and increases the chemosensitivity of colorectal cancer cells to oxaliplatin and fluorouracil (Figure 5), which revealed that RAI2 may serve as a potential biomarker of chemosensitivity in colorectal cancer. This evidence concerns the gene RAI2 and colorectal carcinoma.